HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anti-obesity and anti-diabetic activities of a new beta3 adrenergic receptor agonist, (S)-(Z)-[4-[[1-[2-[(2-hydroxy-3-phenoxypropyl)]amino]ethyl]-1-propenyl] phenoxy] acetic acid ethanedioic acid (SWR-0342SA), in KK-Ay mice.

Abstract
We investigated the beta-adrenergic receptor (AR) agonistic activities in rats and humans, and the anti-obesity and anti-diabetic activities in KK-Ay mice, of a new beta3-AR agonist, SWR-0342SA ((S)-(Z)-[4-[[1-[2-[(2-hydroxy-3-phenoxypropyl)]amino]ethyl]-1-pro penyl]phenoxy] acetic acid ethanedioic acid). With regards to its beta-AR agonistic activity in rats, SWR-0342SA stimulated the atrial beating rate (beta1-AR activity) and white adipocyte lipolysis (beta3-AR activity), but did not induce uterine muscle relaxation (beta2-AR activity). The beta3-AR agonistic activity of SWR-0342SA was about 20 times stronger than its beta1-AR agonistic activity. Similarly, SWR-0342SA enhanced the accumulation of cAMP in Chinese hamster ovary (CHO) cells expressing human beta1- and beta3-ARs, while having no effect in CHO cells expressing beta2-ARs. Adenylyl cyclase stimulation by SWR-0342SA in CHO cells expressing beta3-ARs was about 35 times higher than that in CHO cells expressing beta1-ARs. With regards to anti-obesity and anti-diabetic activities, SWR-0342SA had no effect on body weight or food intake, but slightly decreased the fat pads weight in KK-Ay mice, an animal model of obesity and non-insulin-dependent diabetes mellitus (NIDDM). On the other hand, SWR-0342SA significantly decreased both blood glucose (to about 46% of control) and serum insulin levels (to about 40% of control) in KK-Ay mice. These results indicated that SWR-0342SA is a selective beta3-AR agonist, and possesses potent anti-diabetic activity, and that the anti-obesity activity is inferior to the anti-diabetic activity.
AuthorsT Kiso, T Namikawa, T Tokunaga, K Sawada, T Kakita, T Shogaki, Y Ohtsubo
JournalBiological & pharmaceutical bulletin (Biol Pharm Bull) Vol. 22 Issue 10 Pg. 1073-8 (Oct 1999) ISSN: 0918-6158 [Print] Japan
PMID10549858 (Publication Type: Journal Article)
Chemical References
  • Acetates
  • Adrenergic beta-Agonists
  • Anti-Obesity Agents
  • Hypoglycemic Agents
  • Receptors, Adrenergic, beta
  • Receptors, Adrenergic, beta-3
  • SWR 0342SA
Topics
  • Acetates (pharmacology, therapeutic use)
  • Adrenergic beta-Agonists (pharmacology, therapeutic use)
  • Animals
  • Anti-Obesity Agents (pharmacology, therapeutic use)
  • Body Weight (drug effects)
  • CHO Cells
  • Cricetinae
  • Humans
  • Hypoglycemic Agents (pharmacology, therapeutic use)
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Rats
  • Receptors, Adrenergic, beta (drug effects, metabolism)
  • Receptors, Adrenergic, beta-3
  • Transfection

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: